Exponent - EXPO Stock Forecast, Price & News

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Exponent in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" EXPO shares.
View EXPO analyst ratings or view top-rated stocks.

2 equities research analysts have issued 12 month price targets for Exponent's shares. Their EXPO share price forecasts range from $120.00 to $120.00. On average, they expect the company's stock price to reach $120.00 in the next year. This suggests a possible upside of 18.3% from the stock's current price.
View analysts price targets for EXPO or view top-rated stocks among Wall Street analysts.

Exponent's stock was trading at $99.09 at the beginning of the year. Since then, EXPO stock has increased by 2.4% and is now trading at $101.47.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 2nd 2023.
View our EXPO earnings forecast.

Exponent will be holding an earnings conference call on Thursday, February 2nd at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-0088 with passcode "5182551".

Exponent, Inc. (NASDAQ:EXPO) issued its quarterly earnings results on Thursday, October, 28th. The business services provider reported $0.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.39 by $0.07. The business services provider earned $116.41 million during the quarter, compared to analyst estimates of $104.01 million. Exponent had a net margin of 20.06% and a trailing twelve-month return on equity of 27.40%. The business's quarterly revenue was up 18.0% compared to the same quarter last year. During the same quarter last year, the firm earned $0.34 EPS.

Exponent declared a quarterly dividend on Thursday, October 27th. Shareholders of record on Friday, December 9th will be given a dividend of $0.24 per share on Friday, December 23rd. This represents a $0.96 annualized dividend and a dividend yield of 0.95%. The ex-dividend date is Thursday, December 8th.
Read our dividend analysis for EXPO.

Exponent (NASDAQ:EXPO) pays an annual dividend of $0.96 per share and currently has a dividend yield of 0.95%. The company has been increasing its dividend for 4 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 50.53%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, EXPO will have a dividend payout ratio of 46.60% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for EXPO.

Exponent's stock split on Thursday, June 7th 2018. The 2-1 split was announced on Tuesday, May 15th 2018. The newly created shares were distributed to shareholders after the closing bell on Wednesday, June 6th 2018. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

Exponent updated its FY 2022 earnings guidance on Friday, November, 4th. The company provided EPS guidance of for the period. The company issued revenue guidance of $460.94 million-$465.29 million, compared to the consensus revenue estimate of $503.72 million.

15 employees have rated Exponent Chief Executive Officer Catherine Corrigan on Glassdoor.com. Catherine Corrigan has an approval rating of 84% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Exponent investors own include AbbVie (ABBV), Pfizer (PFE), Abbott Laboratories (ABT), Energy Transfer (ET), Ford Motor (F), Micron Technology (MU), AT&T (T), UnitedHealth Group (UNH), Visa (V) and Adobe (ADBE).

Exponent trades on the NASDAQ under the ticker symbol "EXPO."

Exponent's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Riverbridge Partners LLC (2.09%), Roffman Miller Associates Inc. PA (0.63%), Comerica Bank (0.42%), Vestmark Advisory Solutions Inc. (0.12%), Assenagon Asset Management S.A. (0.12%) and Kingfisher Capital LLC (0.07%). Insiders that own company stock include Bradley A James, Carol Lindstrom, George H Brown, Harri Kytomaa, John Pye, Maureen T F Reitman, Paul R Johnston, Paul R Johnston, Richard L Schlenker Jr, Richard Reiss, Sally Shepard and Steven J Murray.
View institutional ownership trends.

Shares of EXPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of EXPO stock can currently be purchased for approximately $101.47.

Exponent (NASDAQ:EXPO) has a market capitalization of $5.14 billion and generates $466.27 million in revenue each year. The business services provider earns $101.20 million in net income (profit) each year or $1.90 on an earnings per share basis.

The company employs 1,215 workers across the globe.

Exponent's mailing address is 149 COMMONWEALTH DRIVE, MENLO PARK CA, 94025. The official website for the company is www.exponent.com. The business services provider can be reached via phone at (650) 326-9400, via email at investor-relations@exponent.com, or via fax at 650-326-8072.